Hypertension is the most important component of metabolic syndrome in the association with ischemic heart disease in Taiwanese type 2 diabetic patients

Circulation Journal

Volumn 72, Issue 9, 2008, Pages 1419-1424

  Tseng, Chin Hsiao ^a,b   Chong, Choon Khim ^c   Tseng, Ching Ping ^d   Shau, Wen Yi ^a   Tai, Tong Yuan ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Ischemic heart disease; Metabolic syndrome; Risk factors; Taiwan; Type 2 diabetes mellitus

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; STATISTICAL SIGNIFICANCE; TAIWAN; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 50449110473     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0009     Document Type: Article

References (23)

1. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization: Geneva, 1999.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
3. Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care 2004; 27: 1605-1609.
4. Tseng CH. Body mass index and blood pressure in adult type 2 diabetic patients in Taiwan. Circ J 2007; 71: 1749-1754.
5. Tseng CH. Body composition as a risk factor for coronary artery disease in Chinese type 2 diabetic patients in Taiwan. Circ J 2003; 67: 479-484.
6. Tseng CH. Sexual difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients. Circ J 2007; 71: 1131-1136.
7. World Health Organization. International Obesity Taskforce and International Association for the Study of Obesity. The Asia-Pacific perspective: Redefining obesity and its treatment. Hong Kong: WHO, IOTF and IASO, 2000.
8. Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Asia Pac J Clin Nutr 2003; 12: 271-276.
9. Fujimoto WY, Newell-Morris LL, Grote M, Bergstrom RW, Shuman WP. Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese American men and women. Int J Obes 1991; 15(Suppl 2): 41-44.
10. Tseng CH, Chong CK, Lin BJ, Chen CJ, Tai TY. Atherosclerotic risk factors for peripheral vascular disease in non-insulin-dependent diabetic patients. J Formosan Med Assoc 1994; 93: 663-667.
11. Tseng CH. Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients. Kidney Int 2005; 67: 1547-1553.
12. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005; 68: 796-801.
13. Tseng CH. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan. Diabetes Care 2004; 27: 517-521.
14. Fu CC, Chang CJ, Tseng CH, Chen MS, Kao CS, Wu TJ, et al. Development of macrovascular diseases in non-insulin-dependent-diabetics in northern Taiwan: A four-year follow-up study. Diabetes Care 1993; 16: 137-143.
15. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetologia 1985; 28(Suppl): 615-640.
16. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
17. Nakamura Y, Saitoh S, Takagi S, Ohnishi H, Chiba Y, Kato N, et al. Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease. Circ J 2007; 71: 20-25.
18. Pan WH, Chiang BN. Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan: A unique experience. Atherosclerosis 1995; 118: 285-295.
19. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823- 828.
20. Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I, Stampfer MJ, Willett WC, et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002; 162: 273-279.
21. Sakurai A, Oka S, Sekine J, Tanaka H, Nagasawa Y, Numao Y, et al. Changes of ischemic heart disease in Utsunomiya, Japan, over 10 years: A survey of primary care physicians. Jpn Circ J 1998; 62: 675-679.
22. Ogawa K, Numao T, Iizuka M, Yanagisawa A, Yoshino H, Ishikawa K, et al. Angiographic and coronary risk factor analyses of Japanese patients with ischemic heart disease before age 40: A multicenter cooperative study. Jpn Circ J 1996; 60: 822-830.
23. Horenstein RB, Smith DE, Mosca L. Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke 2002; 33: 1863-1868.